https://www.taxtmi.com/news?id=30161 R-Bridge provides a long-term synthetic royalty-backed financing facility to Mirxes as a bespoke, non-dilutive funding solution with a customized, flexible repayment schedule tied to expected product cash flows to accelerate commercialization, market expansion, and continued development of its regulatory-approved miRNA In Vitro Diagnostic tests. en-us Mon, 13 Jan 2025 17:16:03 +0530 Mon, 13 Jan 2025 17:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=30161 R-Bridge provides a long-term synthetic royalty-backed financing facility to Mirxes as a bespoke, non-dilutive funding solution with a customized, flexible repayment schedule tied to expected product cash flows to accelerate commercialization, market expansion, and continued development of its regulatory-approved miRNA In Vitro Diagnostic tests. News - Mon, 13 Jan 2025 17:16:03 +0530 https://www.taxtmi.com/news?id=30161